Predicting Success in the Biotech and Pharma Sectors Mark Schoenebaum of ISI Group earned two top spots on this year's All-America Research Team. Here he explains how he differentiates the good stocks from the bad. Related Articles Late to Private Markets, City of Austin May Have Gotten the Timing Right James Comtois OCIO Boom Is Pushing Smaller Foundations Deeper Into Private Markets James Comtois Is the Lumber-Gold Ratio Signaling Caution for Markets? Sponsored by CME Group